How Fortress Biotech, Inc. stacks up

FBIOP · against 454 other Healthcare companies listed in US-listed

Growth

80/ 100

Above the middle of the pack.

Ranked #145 of 455 · scores higher than 67% of peers

Bars: peers in each 10-point band of the growth score

66 peers with a growth score of 80–89, including FBIOP · Click a bar to see the companies

Why growth scores 80?

Weighted metrics compared with all Healthcare companies.

Mainly thanks to its earnings per share growth and revenue growth, which are stronger than most Healthcare peers.

slower revenue growth over three years: weaker than 62% of peers. 3-year revenue growth: 3.0% vs peer median 5.8%
faster revenue growth over the last year: stronger than 72% of peers. Revenue growth: 15.5% vs peer median 6.1%
faster growth in earnings per share: stronger than 90% of peers. Earnings per share growth: 142.7% vs peer median 9.8%

Metric by metric

Position: dot = FBIOP, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	FBIOP	Peer median	Better than	Weight
Revenue growthHigher is better · 475 reported	15.5%	11.0%	59%	33%
Earnings per share growthHigher is better · 171 reported	142.7%	21.2%	84%	33%
3-year revenue growthHigher is better · 433 reported	3.0%	11.0%	27%	33%

Ranking by growth score

Top 5 and the companies ranked around FBIOP

Rank	Company	Market cap	Growth	Overall
1	Phathom Pharmaceuticals, Inc.PHAT · US-listed	464M USD	100	53
2	AnaptysBio, Inc.ANAB · US-listed	1.4B USD	99	73
2	CorMedix Inc.CRMD · US-listed	433M USD	99	81
2	ImmunityBio, Inc.IBRX · US-listed	8.8B USD	99	31
2	Insight Molecular Diagnostics Inc.IMDX · US-listed	90M USD	99	27
⋯
138	Privia Health Group, Inc.PRVA · US-listed	2.7B USD	81	56
138	SI-BONE, Inc.SIBN · US-listed	1.1B USD	81	50
145	Acadia Pharmaceuticals Inc.ACAD · US-listed	3.5B USD	80	75
145	Cronos Group Inc.CRON · US-listed	1.2B USD	80	67
145	Fortress Biotech, Inc.FBIOP · US-listed	Unavailable	80	56
145	Halozyme Therapeutics, Inc.HALO · US-listed	14.6B USD	80	59
145	Jazz Pharmaceuticals plcJAZZ · US-listed	14.9B USD	80	65
145	Krystal Biotech, Inc.KRYS · US-listed	9.0B USD	80	78
145	Repligen CorporationRGEN · US-listed	10.1B USD	80	61

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…